Enhanced bimatoprost ophthalmic solution
DC CAFCFirst Claim
Patent Images
1. A method of lowering elevated intraocular pressure in a patient with open-angle glaucoma or ocular hypertension which comprises applying to the eyes of the patient an aqueous solution comprised of:
- about 0.01% w/v bimatoprost;
about 200 ppm benzalkonium chloride;
the solution having a pH of about 7.3;
a phosphate buffer; and
,water.
1 Assignment
Litigations
0 Petitions
Accused Products
Abstract
A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein.
A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein.
50 Citations
21 Claims
-
1. A method of lowering elevated intraocular pressure in a patient with open-angle glaucoma or ocular hypertension which comprises applying to the eyes of the patient an aqueous solution comprised of:
-
about 0.01% w/v bimatoprost; about 200 ppm benzalkonium chloride; the solution having a pH of about 7.3; a phosphate buffer; and
,water. - View Dependent Claims (2, 3, 4, 5)
-
-
6. A method of lowering intraocular pressure in a patient suffering from elevated intraocular pressure which comprises applying to the eyes of the patient an aqueous solution comprising:
-
0.01% w/v bimatoprost; about 200 ppm benzalkonium chloride; the solution having a pH of about 7.3; a citric acid buffer; and
,water. - View Dependent Claims (7, 8, 9, 10, 11)
-
-
12. A method of treating glaucoma in a patient comprising the following steps:
-
applying at least once a day a formulation comprising; about 0.01% w/v bimatoprost; benzalkonium chloride in the amount of about 200 ppm; at least one buffering agent selected from the group consisting of dibasic sodium phosphate heptahydrate, citric acid monohydrate and EDTA; and wherein the formulation has a pH of about 7.3. - View Dependent Claims (13, 14, 15, 16, 17)
-
-
18. A method of lowering elevated intraocular pressure in a patient with open-angle glaucoma or ocular hypertension which comprises applying to the eyes of the patient an aqueous solution comprising:
-
0.01% w/v bimatoprost; 0.02% w/v benzalkonium chloride; at least two buffering agents selected from the group consisting of dibasic sodium phosphate heptahydrate, citric acid monohydrate and EDTA; hydrochloric acid and sodium hydroxide to adjust the solution to a pH of about 7.3; sodium chloride; and
,purified water. - View Dependent Claims (19, 20, 21)
-
Specification